HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1201	16261 Jacobs AH, Winkler A, Castro MG, Lowenstein P Human gene therapy and imaging in neurological diseases EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2005 DEC; 32: S358-S383	2	8	39	256
1202	16505 Brandis KA, Holmes IF, England SJ, Sharma N, Kukreia L, et al. alpha-synuclein fission yeast model - Concentration-dependent aggregation without plasma membrane localization or toxicity JOURNAL OF MOLECULAR NEUROSCIENCE. 2006; 28 (2): 179-191	8	9	39	68
1203	16742 Rahman A, Grundke-Iqbal I, Iqbal K PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau JOURNAL OF NEURAL TRANSMISSION. 2006 FEB; 113 (2): 219-230	4	6	39	56
1204	16979 Ahn KJ, Paik SR, Chung KC, Kim J Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein JOURNAL OF NEUROCHEMISTRY. 2006 APR; 97 (1): 265-279	15	18	39	59
1205	17499 Duka T, Sidhu A The neurotoxin, MPP+,, induces hyperphosphorylation of Tau, in the presence of alpha-synuclein, in SH-SY5Y neuroblastoma cells NEUROTOXICITY RESEARCH. 2006 AUG; 10 (1): 1-10	6	8	39	50
1206	17700 Mazzulli JR, Mishizen AJ, Giasson BI, Lynch DR, Thomas SA, et al. Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates JOURNAL OF NEUROSCIENCE. 2006 SEP 27; 26 (39): 10068-10078	30	39	39	54
1207	17862 Halliwell B Proteasomal dysfunction: A common feature of neuro degenerative diseases? Implications for the environmental origins of neurodegeneration ANTIOXIDANTS & REDOX SIGNALING. 2006 NOV-DEC; 8 (11-12): 2007-2019	2	22	39	170
1208	18291 Kovesdi E, Czeiter E, Tamas A, Reglodi D, Szellar D, et al. Rescuing neurons and glia: is inhibition of apoptosis useful? NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 81-95	0	6	39	113
1209	18295 Van Den Heuvel C, Thornton E, Vink R Traumatic brain injury and Alzheimer's disease: a review NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 303-316	11	29	39	121
1210	18587 Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model NEURON. 2007 FEB 1; 53 (3): 337-351	134	134	39	62
#	Date / Author / Journal	LCS	GCS	LCR	CR
1211	19037 Liu C, Fei EK, Jia NL, Wang HF, Tao RS, et al. Assembly of lysine 63-linked ubiquitin conjugates by phosphorylated alpha- synuclein implies Lewy body biogenesis JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 MAY 11; 282 (19): 14558-14566	8	14	39	53
1212	19123 Wilhelmus MMM, de Waal RMW, Verbeek MM Heat shock proteins and amateur chaperones in amyloid-beta accumulation and clearance in Alzheimer's disease MOLECULAR NEUROBIOLOGY. 2007 JUN; 35 (3): 203-216	7	17	39	186
1213	19319 Aoyagi H, Hasegawa M, Tamaoka A Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L Tau but not wild-type Tau JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 JUL 13; 282 (28): 20309-20318	7	10	39	46
1214	19351 Okouchi M, Ekshyyan O, Maracine M, Aw TY, Calabrese V, et al. Neuronal apoptosis in neurodegeneration ANTIOXIDANTS & REDOX SIGNALING. 2007 AUG; 9 (8): 1059-1096	4	44	39	424
1215	19942 Chun WJ, Waldo GS, Johnson GVW Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3 beta activation and caspase 3 cleavage JOURNAL OF NEUROCHEMISTRY. 2007 DEC; 103 (6): 2529-2539	2	11	39	54
1216	20193 Jellinger KA Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia NEURODEGENERATIVE DISEASES. 2008; 5 (3-4): 118-121	9	20	39	46
1217	20729 Andres RH, Meyer M, Ducray AD, Widmer HR Restorative neuroscience: concepts and perspectives SWISS MEDICAL WEEKLY. 2008 MAR 22; 138 (11-12): 155-172	1	1	39	249
1218	20742 Meredith GE, Sonsalla PK, Chesselet MF Animal models of Parkinson's disease progression ACTA NEUROPATHOLOGICA. 2008 APR; 115 (4): 385-398	18	35	39	140
1219	20785 Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, et al. Relationship of phosphorylated alpha-synuclein and tau accumulation to A beta deposition in the cerebral cortex of dementia with Lewy bodies EXPERIMENTAL NEUROLOGY. 2008 APR; 210 (2): 409-420	14	16	39	56
1220	20917 Mackenzie IRA, Foti D, Woulfe J, Hurwitz TA Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions BRAIN. 2008 MAY; 131: 1282-1293	50	52	39	56
#	Date / Author / Journal	LCS	GCS	LCR	CR
1221	21108 Sahara N, Murayama M, Lee B, Park JM, Lagalwar S, et al. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3 beta is required for tau aggregation EUROPEAN JOURNAL OF NEUROSCIENCE. 2008 JUN; 27 (11): 2897-2906	8	14	39	51
1222	21357 Liu F, Gong CX Tau exon 10 alternative splicing and tauopathies MOLECULAR NEURODEGENERATION. 2008 JUL 10; 3: Art. No. 8	1	5	39	73
1223	21378 Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, et al. Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration JOURNAL OF NEUROSCIENCE. 2008 JUL 23; 28 (30): 7687-7698	39	39	39	81
1224	21519 Beach TG, White CL, Hamilton RL, Duda JE, Iwatsubo T, et al. Evaluation of alpha-synuclein immunohistochemical methods used by invited experts ACTA NEUROPATHOLOGICA. 2008 SEP; 116 (3): 277-288	13	17	39	50
1225	21565 Biskup S, Gerlach M, Kupsch A, Reichmann H, Riederer P, et al. Genes associated with Parkinson syndrome JOURNAL OF NEUROLOGY. 2008 SEP; 255: 8-17	6	27	39	96
1226	21860 Chang E, Kim S, Yin H, Nagaraja HN, Kuret J Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps JOURNAL OF NEUROCHEMISTRY. 2008 NOV; 107 (4): 1113-1123	4	6	39	56
1227	22390 Nelson PT, Braak H, Markesbery WR Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 JAN; 68 (1): 1-14	16	35	39	150
1228	22751 Perlmutter JD, Braun AR, Sachs JN Curvature Dynamics of alpha-Synuclein Familial Parkinson Disease Mutants MOLECULAR SIMULATIONS OF THE MICELLE- AND BILAYER-BOUND FORMS JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 MAR 13; 284 (11): 7177-7189	7	8	39	65
1229	22931 Lesage S, Brice A Parkinson's disease: from monogenic forms to genetic susceptibility factors HUMAN MOLECULAR GENETICS. 2009 APR 15; 18: R48-R59	26	71	39	177
1230	23216 Schell H, Hasegawa T, Neumann M, Kahle PJ NUCLEAR AND NEURITIC DISTRIBUTION OF SERINE-129 PHOSPHORYLATED alpha- SYNUCLEIN IN TRANSGENIC MICE NEUROSCIENCE. 2009 JUN 2; 160 (4): 796-804	4	5	39	47
#	Date / Author / Journal	LCS	GCS	LCR	CR
1231	23610 Fitzpatrick KM, Raschke J, Emborg ME Cell-Based Therapies for Parkinson's Disease: Past, Present, and Future ANTIOXIDANTS & REDOX SIGNALING. 2009 SEP; 11 (9): 2189-2208	1	3	39	183
1232	23706 Sneppen K, Lizana L, Jensen MH, Pigolotti S, Otzen D Modeling proteasome dynamics in Parkinson's disease PHYSICAL BIOLOGY. 2009 SEP; 6 (3): Art. No. 036005	0	4	39	78
1233	23921 Kovari E, Horvath J, Bouras C Neuropathology of Lewy body disorders BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 203-210	1	2	39	97
1234	24117 Cuny GD Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions CURRENT PHARMACEUTICAL DESIGN. 2009 DEC; 15 (34): 3919-3939	1	4	39	222
1235	24280 Agostinho P, Cunha RA, Oliveira C Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimer's Disease CURRENT PHARMACEUTICAL DESIGN. 2010; 16 (25): 2766-2778	0	2	39	198
1236	24346 Sonnen JA, Montine KS, Quinn JF, Breitner JCS, Montine TJ Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (1): 301-309	1	1	39	75
1237	24672 Kosmidis S, Grammenoudi S, Papanikolopoulou K, Skoulakis EMC Differential Effects of Tau on the Integrity and Function of Neurons Essential for Learning in Drosophila JOURNAL OF NEUROSCIENCE. 2010 JAN 13; 30 (2): 464-477	3	3	39	83
1238	24755 Luo GR, Le WD Collective Roles of Molecular Chaperones in Protein Degradation Pathways Associated with Neurodegenerative Diseases CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 180-187	1	5	39	79
1239	25322 Wang XY, Moualla D, Wright JA, Brown DR Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity JOURNAL OF NEUROCHEMISTRY. 2010 MAY; 113 (3): 704-714	1	3	39	49
1240	25331 Miranda HV, Outeiro TF The sour side of neurodegenerative disorders: the effects of protein glycation JOURNAL OF PATHOLOGY. 2010 MAY; 221 (1): 13-25	0	3	39	177
#	Date / Author / Journal	LCS	GCS	LCR	CR
1241	25461 Petzold A, Chapman MD, Schraen S, Verwey NA, Pasquier F, et al. An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels EXPERIMENTAL NEUROLOGY. 2010 JUN; 223 (2): 432-438	0	0	39	64
1242	25532 Smith WW, Liu ZH, Liang YD, Masuda N, Swing DA, et al. Synphilin-1 attenuates neuronal degeneration in the A53T alpha- synuclein transgenic mouse model HUMAN MOLECULAR GENETICS. 2010 JUN 1; 19 (11): 2087-2098	1	1	39	52
1243	25895 Tsai KJ, Yang CH, Fang YH, Cho KH, Chien WL, et al. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U JOURNAL OF EXPERIMENTAL MEDICINE. 2010 AUG 2; 207 (8): 1661-1673	1	1	39	59
1244	26153 Waerzeggers Y, Monfared P, Viel T, Winkeler A, Jacobs AH Mouse models in neurological disorders: Applications of non-invasive imaging BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 819-839	0	1	39	241
1245	26223 Dimitriadi M, Hart AC Neurodegenerative disorders: Insights from the nematode Caenorhabditis elegans NEUROBIOLOGY OF DISEASE. 2010 OCT; 40 (1): 4-11	1	2	39	109
1246	26445 Meuvis J, Gerard M, Desender L, Baekelandt V, Engelborghs Y The Conformation and the Aggregation Kinetics of alpha-Synuclein Depend on the Proline Residues in Its C-Terminal Region BIOCHEMISTRY. 2010 NOV 2; 49 (43): 9345-9352	0	0	39	59
1247	26620 Wadsworth JDF, Asante EA, Collinge J Review: Contribution of transgenic models to understanding human prion disease NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 DEC; 36 (7): 576-597	0	0	39	227
1248	26765 Brady OA, Meng P, Zheng YQ, Mao YX, Hu FH Regulation of TDP-43 aggregation by phosphorylation andp62/SQSTM1 JOURNAL OF NEUROCHEMISTRY. 2011 JAN; 116 (2): 248-259	0	0	39	57
1249	26887 Chang E, Kim S, Schafer KN, Kuret J Pseudophosphorylation of tau protein directly modulates its aggregation kinetics BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2011 FEB; 1814 (2): 388-395	0	0	39	57
1250	3768 GOEDERT M, SPILLANTINI MG, JAKES R, CROWTHER RA, VANMECHELEN E, et al. MOLECULAR DISSECTION OF THE PAIRED HELICAL FILAMENT NEUROBIOLOGY OF AGING. 1995 MAY-JUN; 16 (3): 325-334	47	57	38	72
#	Date / Author / Journal	LCS	GCS	LCR	CR
1251	4452 Litersky JM, Johnson GVW, Jakes R, Goedert M, Lee M, et al. Lan protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356 BIOCHEMICAL JOURNAL. 1996 JUN 1; 316: 655-660	59	80	38	60
1252	7284 Godemann R, Biernat J, Mandelkow E, Mandelkow EM Phosphorylation of tau protein by recombinant GSK-3 beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain FEBS LETTERS. 1999 JUL 2; 454 (1-2): 157-164	28	60	38	60
1253	7848 Kahle PJ, Neumann M, Ozmen L, Haass C Physiology and pathophysiology of alpha-synuclein - Cell culture and transgenic animal models based on a Parkinson's disease-associated protein MOLECULAR BASIS OF DEMENTIA. 2000; 920: 33-41	33	37	38	62
1254	8136 Czech C, Tremp G, Pradier L Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms PROGRESS IN NEUROBIOLOGY. 2000 MAR; 60 (4): 363-384	17	88	38	194
1255	8406 Avila J Tau aggregation into fibrillar polymers: taupathies FEBS LETTERS. 2000 JUN 30; 476 (1-2): 89-92	23	35	38	60
1256	9023 Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, et al. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies JOURNAL OF NEURAL TRANSMISSION. 2001; 108 (12): 1383-1396	24	71	38	64
1257	9924 Wong PC, Cai HB, Borchelt DR, Price DL Genetically engineered models relevant to neurodegenerative disorders - Their value for understanding disease mechanisms and designing/testing experimental therapeutics JOURNAL OF MOLECULAR NEUROSCIENCE. 2001 OCT; 17 (2): 233-257	5	8	38	211
1258	10142 Lim F, Hernandez F, Lucas JJ, Gomez-Ramos P, Moran MA, et al. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and tau filaments in forebrain MOLECULAR AND CELLULAR NEUROSCIENCE. 2001 DEC; 18 (6): 702-714	71	83	38	53
1259	10177 Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death JOURNAL OF NEUROSCIENCE. 2001 DEC 15; 21 (24): 9549-9560	151	234	38	75
1260	10451 Jo EJ, Fuller N, Rand RP, St George-Hyslop P, Fraser PE Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein JOURNAL OF MOLECULAR BIOLOGY. 2002 JAN 25; 315 (4): 799-807	68	75	38	53
#	Date / Author / Journal	LCS	GCS	LCR	CR
1261	10827 Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, et al. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila NEURON. 2002 MAY 16; 34 (4): 509-519	162	206	38	89
1262	11070 El-Agnaf OMA, Irvine GB Aggregation and neurotoxicity of alpha-synuclein and related peptides BIOCHEMICAL SOCIETY TRANSACTIONS. 2002 AUG; 30: 559-565	37	53	38	43
1263	11216 Tian Q, Wang JZ Role of serine/threonine protein phosphatase in Alzheimer's disease NEUROSIGNALS. 2002 SEP-OCT; 11 (5): 262-269	38	59	38	96
1264	11287 Jackson M, Llado J, Rothstein JD Therapeutic developments in the treatment of amyotrophic lateral sclerosis EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2002 OCT; 11 (10): 1343-1364	7	15	38	232
1265	11312 Rideout HJ, Stefanis L Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination MOLECULAR AND CELLULAR NEUROSCIENCE. 2002 OCT; 21 (2): 223-238	32	65	38	74
1266	11388 Liu F, Iqbal K, Grundke-Iqbal I, Gong CX Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3 beta FEBS LETTERS. 2002 OCT 23; 530 (1-3): 209-214	26	54	38	54
1267	12048 Lee EN, Lee SY, Lee D, Kim J, Paik SR Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2 JOURNAL OF NEUROCHEMISTRY. 2003 MAR; 84 (5): 1128-1142	18	29	38	64
1268	12238 Goellner GM, Rechsteiner M Are Huntington's and polyglutamine-based ataxias proteasorne storage diseases? INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2003 MAY; 35 (5): 562-571	6	26	38	108
1269	12442 Jensen PJ, Alter BJ, O'Malley KL alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity JOURNAL OF NEUROCHEMISTRY. 2003 JUL; 86 (1): 196-209	17	21	38	72
1270	12547 Mori F, Piao YS, Hayashi S, Fujiwara H, Hasegawa M, et al. alpha-Synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 AUG; 62 (8): 812-819	15	18	38	50
#	Date / Author / Journal	LCS	GCS	LCR	CR
1271	12903 Uryu K, Giasson BI, Longhi L, Martinez D, Murray I, et al. Age-dependent synuclein pathology following traumatic brain injury in mice EXPERIMENTAL NEUROLOGY. 2003 NOV; 184 (1): 214-224	24	24	38	53
1272	13053 Wood JD, Beaujeux TP, Shaw PJ Protein aggregation in motor neurone disorders NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 DEC; 29 (6): 529-545	26	61	38	124
1273	13428 Bramlett HM, Dietrich WD Pathophysiology of cerebral ischemia and brain trauma: Similarities and differences JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2004 FEB; 24 (2): 133-150	24	126	38	282
1274	13448 Boutajangout A, Authelet M, Blanchard V, Touchet N, Tremp G, et al. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1 NEUROBIOLOGY OF DISEASE. 2004 FEB; 15 (1): 47-60	23	36	38	59
1275	13869 Wilson CA, Murphy DD, Giasson BI, Zhang B, Trojanowski JQ, et al. Degradative organelles containing mislocalized alpha- and beta-synuclein proliferate in presenilin-1 null neurons JOURNAL OF CELL BIOLOGY. 2004 MAY 10; 165 (3): 335-346	42	42	38	78
1276	14131 Rekas A, Adda CG, Aquilina JA, Barnham KJ, Sunde M, et al. Interaction of the molecular chaperone alpha B-crystallin with alpha- synuclein: Effects on amyloid fibril formation and chaperone activity JOURNAL OF MOLECULAR BIOLOGY. 2004 JUL 23; 340 (5): 1167-1183	23	59	38	67
1277	14158 Jo E, Darabie AA, Han K, Tandon A, Fraser PE, et al. alpha-synuclein-synaptosomal membrane interactions - Implications for fibrillogenesis EUROPEAN JOURNAL OF BIOCHEMISTRY. 2004 AUG; 271 (15): 3180-3189	21	27	38	54
1278	14286 de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, et al. MRI and CSF studies in the early diagnosis of Alzheimer's disease JOURNAL OF INTERNAL MEDICINE. 2004 SEP; 256 (3): 205-223	24	66	38	156
1279	14504 Richter-Landsberg C, Bauer NG Tau-inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 2004 NOV; 22 (7): 443-451	12	18	38	62
1280	14870 Wiltfang J, Lewczuk P, Riederer P, Grunblatt E, Hock C, et al. Consensus paper of the WFSBP Task Force on biological markers of dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2005; 6 (2): 69-84	25	60	38	134
#	Date / Author / Journal	LCS	GCS	LCR	CR
1281	15015 Ikeda M, Shoji M, Kawarai T, Kawarabayashi T, Matsubara E, et al. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice AMERICAN JOURNAL OF PATHOLOGY. 2005 FEB; 166 (2): 521-531	28	30	38	50
1282	15573 Norris EH, Giasson BI, Hodara R, Xu SH, Trojanowski JQ, et al. Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JUN 3; 280 (22): 21212-21219	79	79	38	48
1283	15765 Shaw PJ Molecular and cellular pathways of neurodegeneration in motor neurone disease JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2005 AUG; 76 (8): 1046-1057	23	88	38	162
1284	16288 Cantuti-Castelvetri I, Klucken J, Ingelsson M, Ramasamy K, McLean PJ, et al. Alpha-synuclein and chaperones in dementia with Lewy bodies JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 DEC; 64 (12): 1058-1066	12	15	38	68
1285	16737 Tatebayashi Y, Planel E, Chui DH, Sato S, Miyasaka T, et al. c-jun N-terminal kinase hyperphosphorylates R406W tau at the PHF-1 site during mitosis FASEB JOURNAL. 2006 FEB; 20 (2): 762-+	5	8	38	64
1286	16772 Taylor JP, Mata IF, Farrer MJ LRRK2: a common pathway for parkinsonism, pathogenesis and prevention? TRENDS IN MOLECULAR MEDICINE. 2006 FEB; 12 (2): 76-82	20	44	38	86
1287	17137 Sung YH, Eliezer D Secondary structure and dynamics of micelle bound beta- and gamma- synuclein PROTEIN SCIENCE. 2006 MAY; 15 (5): 1162-1174	14	15	38	67
1288	17216 Gosal D, Ross OA, Toft M Parkinson's disease: the genetics of a heterogeneous disorder EUROPEAN JOURNAL OF NEUROLOGY. 2006 JUN; 13 (6): 616-627	7	21	38	121
1289	17370 Savitt JM, Dawson VL, Dawson TM Diagnosis and treatment of Parkinson disease: molecules to medicine JOURNAL OF CLINICAL INVESTIGATION. 2006 JUL; 116 (7): 1744-1754	40	105	38	125
1290	17466 Millecamps S, Robertson J, Lariviere R, Mallet J, Julien JP Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin JOURNAL OF NEUROCHEMISTRY. 2006 AUG; 98 (3): 926-938	11	18	38	79
#	Date / Author / Journal	LCS	GCS	LCR	CR
1291	17504 Shadrina MI, Slominsky PA Molecular genetics of Parkinson's disease RUSSIAN JOURNAL OF GENETICS. 2006 AUG; 42 (8): 858-871	0	0	38	163
1292	17699 Yuan AD, Rao MV, Sasaki T, Chen YX, Kumar A, et al. alpha-Internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS JOURNAL OF NEUROSCIENCE. 2006 SEP 27; 26 (39): 10006-10019	13	39	38	93
1293	17835 Horowitz PM, LaPointe N, Guillozet-Bongaarts AL, Berry RW, Binder LI N-terminal fragments of tau inhibit full-length tau polymerization in vitro BIOCHEMISTRY. 2006 OCT 24; 45 (42): 12859-12866	11	11	38	52
1294	18759 Planel E, Richter KEG, Nolan CE, Finley JE, Liu L, et al. Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia JOURNAL OF NEUROSCIENCE. 2007 MAR 21; 27 (12): 3090-3097	24	52	38	73
1295	18768 Riederer BM Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein BRAIN RESEARCH BULLETIN. 2007 MAR 30; 71 (6): 541-558	2	29	38	256
1296	18781 Lohmann-Hedrich K, Bruggemann N, Hagenah J, Klein C Parkinson's disease and its genetic origins - Current status AKTUELLE NEUROLOGIE. 2007 APR; 34 (3): 151-161	0	0	38	114
1297	18794 Balastik M, Lim J, Pastorino L, Lu KP Pin1 in Alzheimer's disease: Multiple substrates, one regulatory mechanism? BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2007 APR; 1772 (4): 422-429	4	22	38	106
1298	18878 Adalbert R, Gilley J, Coleman MP A beta, tau and ApoE4 in Alzheimer's disease: the axonal connect ion TRENDS IN MOLECULAR MEDICINE. 2007 APR; 13 (4): 135-142	6	16	38	80
1299	19174 Virdee K, Yoshida H, Peak-Chew S, Goedert M Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily FEBS LETTERS. 2007 JUN 12; 581 (14): 2657-2662	2	4	38	54
1300	19458 Chen M, Margittai M, Chen J, Langen R Investigation of alpha-synuclein fibril structure by site-directed spin labeling JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 AUG 24; 282 (34): 24970-24979	25	50	38	69

Date / Author / Journal

LCS

GCS

LCR

1201

16261 Jacobs AH, Winkler A, Castro MG, Lowenstein P

Human gene therapy and imaging in neurological diseases

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2005 DEC; 32: S358-S383

256

1202

16505 Brandis KA, Holmes IF, England SJ, Sharma N, Kukreia L, et al.

alpha-synuclein fission yeast model - Concentration-dependent aggregation without plasma membrane localization or toxicity

JOURNAL OF MOLECULAR NEUROSCIENCE. 2006; 28 (2): 179-191

1203

16742 Rahman A, Grundke-Iqbal I, Iqbal K

PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau

JOURNAL OF NEURAL TRANSMISSION. 2006 FEB; 113 (2): 219-230

1204

16979 Ahn KJ, Paik SR, Chung KC, Kim J

Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein

JOURNAL OF NEUROCHEMISTRY. 2006 APR; 97 (1): 265-279

1205

17499 Duka T, Sidhu A

The neurotoxin, MPP+,, induces hyperphosphorylation of Tau, in the presence of alpha-synuclein, in SH-SY5Y neuroblastoma cells

NEUROTOXICITY RESEARCH. 2006 AUG; 10 (1): 1-10

1206

17700 Mazzulli JR, Mishizen AJ, Giasson BI, Lynch DR, Thomas SA, et al.

Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates

JOURNAL OF NEUROSCIENCE. 2006 SEP 27; 26 (39): 10068-10078

1207

17862 Halliwell B

Proteasomal dysfunction: A common feature of neuro degenerative diseases? Implications for the environmental origins of neurodegeneration

ANTIOXIDANTS & REDOX SIGNALING. 2006 NOV-DEC; 8 (11-12): 2007-2019

170

1208

18291 Kovesdi E, Czeiter E, Tamas A, Reglodi D, Szellar D, et al.

Rescuing neurons and glia: is inhibition of apoptosis useful?

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 81-95

113

1209

18295 Van Den Heuvel C, Thornton E, Vink R

Traumatic brain injury and Alzheimer's disease: a review

NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT. 2007; 161: 303-316

121

1210

18587 Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, et al.

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

NEURON. 2007 FEB 1; 53 (3): 337-351

134

Date / Author / Journal

LCS

GCS

LCR

1211

19037 Liu C, Fei EK, Jia NL, Wang HF, Tao RS, et al.

Assembly of lysine 63-linked ubiquitin conjugates by phosphorylated alpha- synuclein implies Lewy body biogenesis

JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 MAY 11; 282 (19): 14558-14566

1212

19123 Wilhelmus MMM, de Waal RMW, Verbeek MM

Heat shock proteins and amateur chaperones in amyloid-beta accumulation and clearance in Alzheimer's disease

MOLECULAR NEUROBIOLOGY. 2007 JUN; 35 (3): 203-216

186

1213

19319 Aoyagi H, Hasegawa M, Tamaoka A

Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L Tau but not wild-type Tau

JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 JUL 13; 282 (28): 20309-20318

1214

19351 Okouchi M, Ekshyyan O, Maracine M, Aw TY, Calabrese V, et al.

Neuronal apoptosis in neurodegeneration

ANTIOXIDANTS & REDOX SIGNALING. 2007 AUG; 9 (8): 1059-1096

424

1215

19942 Chun WJ, Waldo GS, Johnson GVW

Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3 beta activation and caspase 3 cleavage

JOURNAL OF NEUROCHEMISTRY. 2007 DEC; 103 (6): 2529-2539

1216

20193 Jellinger KA

Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia

NEURODEGENERATIVE DISEASES. 2008; 5 (3-4): 118-121

1217

20729 Andres RH, Meyer M, Ducray AD, Widmer HR

Restorative neuroscience: concepts and perspectives

SWISS MEDICAL WEEKLY. 2008 MAR 22; 138 (11-12): 155-172

249

1218

20742 Meredith GE, Sonsalla PK, Chesselet MF

Animal models of Parkinson's disease progression

ACTA NEUROPATHOLOGICA. 2008 APR; 115 (4): 385-398

140

1219

20785 Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, et al.

Relationship of phosphorylated alpha-synuclein and tau accumulation to A beta deposition in the cerebral cortex of dementia with Lewy bodies

EXPERIMENTAL NEUROLOGY. 2008 APR; 210 (2): 409-420

1220

20917 Mackenzie IRA, Foti D, Woulfe J, Hurwitz TA

Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions

BRAIN. 2008 MAY; 131: 1282-1293

Date / Author / Journal

LCS

GCS

LCR

1221

21108 Sahara N, Murayama M, Lee B, Park JM, Lagalwar S, et al.

Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3 beta is required for tau aggregation

EUROPEAN JOURNAL OF NEUROSCIENCE. 2008 JUN; 27 (11): 2897-2906

1222

21357 Liu F, Gong CX

Tau exon 10 alternative splicing and tauopathies

MOLECULAR NEURODEGENERATION. 2008 JUL 10; 3: Art. No. 8

1223

21378 Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, et al.

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration

JOURNAL OF NEUROSCIENCE. 2008 JUL 23; 28 (30): 7687-7698

1224

21519 Beach TG, White CL, Hamilton RL, Duda JE, Iwatsubo T, et al.

Evaluation of alpha-synuclein immunohistochemical methods used by invited experts

ACTA NEUROPATHOLOGICA. 2008 SEP; 116 (3): 277-288

1225

21565 Biskup S, Gerlach M, Kupsch A, Reichmann H, Riederer P, et al.

Genes associated with Parkinson syndrome

JOURNAL OF NEUROLOGY. 2008 SEP; 255: 8-17

1226

21860 Chang E, Kim S, Yin H, Nagaraja HN, Kuret J

Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps

JOURNAL OF NEUROCHEMISTRY. 2008 NOV; 107 (4): 1113-1123

1227

22390 Nelson PT, Braak H, Markesbery WR

Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2009 JAN; 68 (1): 1-14

150

1228

22751 Perlmutter JD, Braun AR, Sachs JN

Curvature Dynamics of alpha-Synuclein Familial Parkinson Disease Mutants MOLECULAR SIMULATIONS OF THE MICELLE- AND BILAYER-BOUND FORMS

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 MAR 13; 284 (11): 7177-7189

1229

22931 Lesage S, Brice A

Parkinson's disease: from monogenic forms to genetic susceptibility factors

HUMAN MOLECULAR GENETICS. 2009 APR 15; 18: R48-R59

177

1230

23216 Schell H, Hasegawa T, Neumann M, Kahle PJ

NUCLEAR AND NEURITIC DISTRIBUTION OF SERINE-129 PHOSPHORYLATED alpha- SYNUCLEIN IN TRANSGENIC MICE

NEUROSCIENCE. 2009 JUN 2; 160 (4): 796-804

Date / Author / Journal

LCS

GCS

LCR

1231

23610 Fitzpatrick KM, Raschke J, Emborg ME

Cell-Based Therapies for Parkinson's Disease: Past, Present, and Future

ANTIOXIDANTS & REDOX SIGNALING. 2009 SEP; 11 (9): 2189-2208

183

1232

23706 Sneppen K, Lizana L, Jensen MH, Pigolotti S, Otzen D

Modeling proteasome dynamics in Parkinson's disease

PHYSICAL BIOLOGY. 2009 SEP; 6 (3): Art. No. 036005

1233

23921 Kovari E, Horvath J, Bouras C

Neuropathology of Lewy body disorders

BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 203-210

1234

24117 Cuny GD

Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions

CURRENT PHARMACEUTICAL DESIGN. 2009 DEC; 15 (34): 3919-3939

222

1235

24280 Agostinho P, Cunha RA, Oliveira C

Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimer's Disease

CURRENT PHARMACEUTICAL DESIGN. 2010; 16 (25): 2766-2778

198

1236

24346 Sonnen JA, Montine KS, Quinn JF, Breitner JCS, Montine TJ

Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia

JOURNAL OF ALZHEIMERS DISEASE. 2010; 19 (1): 301-309

1237

24672 Kosmidis S, Grammenoudi S, Papanikolopoulou K, Skoulakis EMC

Differential Effects of Tau on the Integrity and Function of Neurons Essential for Learning in Drosophila

JOURNAL OF NEUROSCIENCE. 2010 JAN 13; 30 (2): 464-477

1238

24755 Luo GR, Le WD

Collective Roles of Molecular Chaperones in Protein Degradation Pathways Associated with Neurodegenerative Diseases

CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2010 FEB; 11 (2): 180-187

1239

25322 Wang XY, Moualla D, Wright JA, Brown DR

Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity

JOURNAL OF NEUROCHEMISTRY. 2010 MAY; 113 (3): 704-714

1240

25331 Miranda HV, Outeiro TF

The sour side of neurodegenerative disorders: the effects of protein glycation

JOURNAL OF PATHOLOGY. 2010 MAY; 221 (1): 13-25

177

Date / Author / Journal

LCS

GCS

LCR

1241

25461 Petzold A, Chapman MD, Schraen S, Verwey NA, Pasquier F, et al.

An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels

EXPERIMENTAL NEUROLOGY. 2010 JUN; 223 (2): 432-438

1242

25532 Smith WW, Liu ZH, Liang YD, Masuda N, Swing DA, et al.

Synphilin-1 attenuates neuronal degeneration in the A53T alpha- synuclein transgenic mouse model

HUMAN MOLECULAR GENETICS. 2010 JUN 1; 19 (11): 2087-2098

1243

25895 Tsai KJ, Yang CH, Fang YH, Cho KH, Chien WL, et al.

Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U

JOURNAL OF EXPERIMENTAL MEDICINE. 2010 AUG 2; 207 (8): 1661-1673

1244

26153 Waerzeggers Y, Monfared P, Viel T, Winkeler A, Jacobs AH

Mouse models in neurological disorders: Applications of non-invasive imaging

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 819-839

241

1245

26223 Dimitriadi M, Hart AC

Neurodegenerative disorders: Insights from the nematode Caenorhabditis elegans

NEUROBIOLOGY OF DISEASE. 2010 OCT; 40 (1): 4-11

109

1246

26445 Meuvis J, Gerard M, Desender L, Baekelandt V, Engelborghs Y

The Conformation and the Aggregation Kinetics of alpha-Synuclein Depend on the Proline Residues in Its C-Terminal Region

BIOCHEMISTRY. 2010 NOV 2; 49 (43): 9345-9352

1247

26620 Wadsworth JDF, Asante EA, Collinge J

Review: Contribution of transgenic models to understanding human prion disease

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 DEC; 36 (7): 576-597

227

1248

26765 Brady OA, Meng P, Zheng YQ, Mao YX, Hu FH

Regulation of TDP-43 aggregation by phosphorylation andp62/SQSTM1

JOURNAL OF NEUROCHEMISTRY. 2011 JAN; 116 (2): 248-259

1249

26887 Chang E, Kim S, Schafer KN, Kuret J

Pseudophosphorylation of tau protein directly modulates its aggregation kinetics

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2011 FEB; 1814 (2): 388-395

1250

3768 GOEDERT M, SPILLANTINI MG, JAKES R, CROWTHER RA, VANMECHELEN E, et al.

MOLECULAR DISSECTION OF THE PAIRED HELICAL FILAMENT

NEUROBIOLOGY OF AGING. 1995 MAY-JUN; 16 (3): 325-334

Date / Author / Journal

LCS

GCS

LCR

1251

4452 Litersky JM, Johnson GVW, Jakes R, Goedert M, Lee M, et al.

Lan protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356

BIOCHEMICAL JOURNAL. 1996 JUN 1; 316: 655-660

1252

7284 Godemann R, Biernat J, Mandelkow E, Mandelkow EM

Phosphorylation of tau protein by recombinant GSK-3 beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain

FEBS LETTERS. 1999 JUL 2; 454 (1-2): 157-164

1253

7848 Kahle PJ, Neumann M, Ozmen L, Haass C

Physiology and pathophysiology of alpha-synuclein - Cell culture and transgenic animal models based on a Parkinson's disease-associated protein

MOLECULAR BASIS OF DEMENTIA. 2000; 920: 33-41

1254

8136 Czech C, Tremp G, Pradier L

Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms

PROGRESS IN NEUROBIOLOGY. 2000 MAR; 60 (4): 363-384

194

1255

8406 Avila J

Tau aggregation into fibrillar polymers: taupathies

FEBS LETTERS. 2000 JUN 30; 476 (1-2): 89-92

1256

9023 Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, et al.

Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies

JOURNAL OF NEURAL TRANSMISSION. 2001; 108 (12): 1383-1396

1257

9924 Wong PC, Cai HB, Borchelt DR, Price DL

Genetically engineered models relevant to neurodegenerative disorders - Their value for understanding disease mechanisms and designing/testing experimental therapeutics

JOURNAL OF MOLECULAR NEUROSCIENCE. 2001 OCT; 17 (2): 233-257

211

1258

10142 Lim F, Hernandez F, Lucas JJ, Gomez-Ramos P, Moran MA, et al.

FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and tau filaments in forebrain

MOLECULAR AND CELLULAR NEUROSCIENCE. 2001 DEC; 18 (6): 702-714

1259

10177 Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA

Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death

JOURNAL OF NEUROSCIENCE. 2001 DEC 15; 21 (24): 9549-9560

151

234

1260

10451 Jo EJ, Fuller N, Rand RP, St George-Hyslop P, Fraser PE

Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein

JOURNAL OF MOLECULAR BIOLOGY. 2002 JAN 25; 315 (4): 799-807

Date / Author / Journal

LCS

GCS

LCR

1261

10827 Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, et al.

Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila

NEURON. 2002 MAY 16; 34 (4): 509-519

162

206

1262

11070 El-Agnaf OMA, Irvine GB

Aggregation and neurotoxicity of alpha-synuclein and related peptides

BIOCHEMICAL SOCIETY TRANSACTIONS. 2002 AUG; 30: 559-565

1263

11216 Tian Q, Wang JZ

Role of serine/threonine protein phosphatase in Alzheimer's disease

NEUROSIGNALS. 2002 SEP-OCT; 11 (5): 262-269

1264

11287 Jackson M, Llado J, Rothstein JD

Therapeutic developments in the treatment of amyotrophic lateral sclerosis

EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2002 OCT; 11 (10): 1343-1364

232

1265

11312 Rideout HJ, Stefanis L

Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination

MOLECULAR AND CELLULAR NEUROSCIENCE. 2002 OCT; 21 (2): 223-238

1266

11388 Liu F, Iqbal K, Grundke-Iqbal I, Gong CX

Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3 beta

FEBS LETTERS. 2002 OCT 23; 530 (1-3): 209-214

1267

12048 Lee EN, Lee SY, Lee D, Kim J, Paik SR

Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2

JOURNAL OF NEUROCHEMISTRY. 2003 MAR; 84 (5): 1128-1142

1268

12238 Goellner GM, Rechsteiner M

Are Huntington's and polyglutamine-based ataxias proteasorne storage diseases?

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 2003 MAY; 35 (5): 562-571

108

1269

12442 Jensen PJ, Alter BJ, O'Malley KL

alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity

JOURNAL OF NEUROCHEMISTRY. 2003 JUL; 86 (1): 196-209

1270

12547 Mori F, Piao YS, Hayashi S, Fujiwara H, Hasegawa M, et al.

alpha-Synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2003 AUG; 62 (8): 812-819

Date / Author / Journal

LCS

GCS

LCR

1271

12903 Uryu K, Giasson BI, Longhi L, Martinez D, Murray I, et al.

Age-dependent synuclein pathology following traumatic brain injury in mice

EXPERIMENTAL NEUROLOGY. 2003 NOV; 184 (1): 214-224

1272

13053 Wood JD, Beaujeux TP, Shaw PJ

Protein aggregation in motor neurone disorders

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 DEC; 29 (6): 529-545

124

1273

13428 Bramlett HM, Dietrich WD

Pathophysiology of cerebral ischemia and brain trauma: Similarities and differences

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2004 FEB; 24 (2): 133-150

126

282

1274

13448 Boutajangout A, Authelet M, Blanchard V, Touchet N, Tremp G, et al.

Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1

NEUROBIOLOGY OF DISEASE. 2004 FEB; 15 (1): 47-60

1275

13869 Wilson CA, Murphy DD, Giasson BI, Zhang B, Trojanowski JQ, et al.

Degradative organelles containing mislocalized alpha- and beta-synuclein proliferate in presenilin-1 null neurons

JOURNAL OF CELL BIOLOGY. 2004 MAY 10; 165 (3): 335-346

1276

14131 Rekas A, Adda CG, Aquilina JA, Barnham KJ, Sunde M, et al.

Interaction of the molecular chaperone alpha B-crystallin with alpha- synuclein: Effects on amyloid fibril formation and chaperone activity

JOURNAL OF MOLECULAR BIOLOGY. 2004 JUL 23; 340 (5): 1167-1183

1277

14158 Jo E, Darabie AA, Han K, Tandon A, Fraser PE, et al.

alpha-synuclein-synaptosomal membrane interactions - Implications for fibrillogenesis

EUROPEAN JOURNAL OF BIOCHEMISTRY. 2004 AUG; 271 (15): 3180-3189

1278

14286 de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, et al.

MRI and CSF studies in the early diagnosis of Alzheimer's disease

JOURNAL OF INTERNAL MEDICINE. 2004 SEP; 256 (3): 205-223

156

1279

14504 Richter-Landsberg C, Bauer NG

Tau-inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE. 2004 NOV; 22 (7): 443-451

1280

14870 Wiltfang J, Lewczuk P, Riederer P, Grunblatt E, Hock C, et al.

Consensus paper of the WFSBP Task Force on biological markers of dementia: The role of CSF and blood analysis in the early and differential diagnosis of dementia

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY. 2005; 6 (2): 69-84

134

Date / Author / Journal

LCS

GCS

LCR

1281

15015 Ikeda M, Shoji M, Kawarai T, Kawarabayashi T, Matsubara E, et al.

Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice

AMERICAN JOURNAL OF PATHOLOGY. 2005 FEB; 166 (2): 521-531

1282

15573 Norris EH, Giasson BI, Hodara R, Xu SH, Trojanowski JQ, et al.

Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JUN 3; 280 (22): 21212-21219

1283

15765 Shaw PJ

Molecular and cellular pathways of neurodegeneration in motor neurone disease

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2005 AUG; 76 (8): 1046-1057

162

1284

16288 Cantuti-Castelvetri I, Klucken J, Ingelsson M, Ramasamy K, McLean PJ, et al.

Alpha-synuclein and chaperones in dementia with Lewy bodies

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 DEC; 64 (12): 1058-1066

1285

16737 Tatebayashi Y, Planel E, Chui DH, Sato S, Miyasaka T, et al.

c-jun N-terminal kinase hyperphosphorylates R406W tau at the PHF-1 site during mitosis

FASEB JOURNAL. 2006 FEB; 20 (2): 762-+

1286

16772 Taylor JP, Mata IF, Farrer MJ

LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?

TRENDS IN MOLECULAR MEDICINE. 2006 FEB; 12 (2): 76-82

1287

17137 Sung YH, Eliezer D

Secondary structure and dynamics of micelle bound beta- and gamma- synuclein

PROTEIN SCIENCE. 2006 MAY; 15 (5): 1162-1174

1288

17216 Gosal D, Ross OA, Toft M

Parkinson's disease: the genetics of a heterogeneous disorder

EUROPEAN JOURNAL OF NEUROLOGY. 2006 JUN; 13 (6): 616-627

121

1289

17370 Savitt JM, Dawson VL, Dawson TM

Diagnosis and treatment of Parkinson disease: molecules to medicine

JOURNAL OF CLINICAL INVESTIGATION. 2006 JUL; 116 (7): 1744-1754

105

125

1290

17466 Millecamps S, Robertson J, Lariviere R, Mallet J, Julien JP

Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin

JOURNAL OF NEUROCHEMISTRY. 2006 AUG; 98 (3): 926-938

Date / Author / Journal

LCS

GCS

LCR

1291

17504 Shadrina MI, Slominsky PA

Molecular genetics of Parkinson's disease

RUSSIAN JOURNAL OF GENETICS. 2006 AUG; 42 (8): 858-871

163

1292

17699 Yuan AD, Rao MV, Sasaki T, Chen YX, Kumar A, et al.

alpha-Internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS

JOURNAL OF NEUROSCIENCE. 2006 SEP 27; 26 (39): 10006-10019

1293

17835 Horowitz PM, LaPointe N, Guillozet-Bongaarts AL, Berry RW, Binder LI

N-terminal fragments of tau inhibit full-length tau polymerization in vitro

BIOCHEMISTRY. 2006 OCT 24; 45 (42): 12859-12866

1294

18759 Planel E, Richter KEG, Nolan CE, Finley JE, Liu L, et al.

Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia

JOURNAL OF NEUROSCIENCE. 2007 MAR 21; 27 (12): 3090-3097

1295

18768 Riederer BM

Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein

BRAIN RESEARCH BULLETIN. 2007 MAR 30; 71 (6): 541-558

256

1296

18781 Lohmann-Hedrich K, Bruggemann N, Hagenah J, Klein C

Parkinson's disease and its genetic origins - Current status

AKTUELLE NEUROLOGIE. 2007 APR; 34 (3): 151-161

114

1297

18794 Balastik M, Lim J, Pastorino L, Lu KP

Pin1 in Alzheimer's disease: Multiple substrates, one regulatory mechanism?

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2007 APR; 1772 (4): 422-429

106

1298

18878 Adalbert R, Gilley J, Coleman MP

A beta, tau and ApoE4 in Alzheimer's disease: the axonal connect ion

TRENDS IN MOLECULAR MEDICINE. 2007 APR; 13 (4): 135-142

1299

19174 Virdee K, Yoshida H, Peak-Chew S, Goedert M

Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily

FEBS LETTERS. 2007 JUN 12; 581 (14): 2657-2662

1300

19458 Chen M, Margittai M, Chen J, Langen R

Investigation of alpha-synuclein fibril structure by site-directed spin labeling

JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 AUG 24; 282 (34): 24970-24979

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records